Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Roots Analysis | PRODUCT CODE: 1215500

Cover Image

PUBLISHER: Roots Analysis | PRODUCT CODE: 1215500

Modular Construction Market in Pharmaceutical & Biotechnology-Distribution by Size & Purposeof Facility, Scale of Operation, Type of Industry Served, Material Used & Key Geographical Regions: Industry Trends & Global Forecasts, 2023-2035

PUBLISHED:
PAGES: 387 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4799
PDF (One-Location Site License)
USD 6999
PDF (Department License)
USD 10599
PDF (Enterprise License)
USD 17999

Add to Cart

INTRODUCTION

In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting; these modular units are later assembled on site. It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns. Further, modular facilities can be built 40% faster as compared to a conventional construction, which could take up to three years. Therefore, considering the various advantages offered by this approach, several pharmaceutical players are now shifting their focus from conventional plants to modular facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines. To provide more context, modular biomanufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability. In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user. However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products.

SCOPE OF THE REPORT

"The Modular Facilities in Pharmaceutical and Biotechnology Market (3rd Edition), 2023-2035, Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Expansion (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report features an extensive study of the current market landscape and future opportunity, offering an informed opinion on the likely adoption of modular facilities in the pharmaceutical and biotechnology industries, over the next 12 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. The report answers the following key questions related to this domain.

Key Advantages Offered by Modular Facilities

Modular facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability. In addition, better quality of products can be achieved by modular construction approaches owing to the fact that modules are built in a controlled factory setting. In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.

Current Market Landscape of Modular Facilities

The modular facilities market landscape features an extensive list of over 50 large, mid-sized, small and very small players. It is worth highlighting that more than 250 players are engaged in offering modular cleanrooms, along with various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry. It is expected that modular facilities will become more streamlined and standardized in the future, serving as an efficient cost saving solution. Additionally, modular techniques allow building of smaller and specialized processing plants whenever rapid deployment of a therapy becomes critical in both developed and developing countries. Further, many, if not most, expansions and new facilities in the pharmaceutical and biotechnology industry are likely to be modular constructions in the near future.

Key Drivers in the Modular Facilities Market

Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models.

Overall Size of Modular Facilities Market

Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with adoption of modular facilities, this market is expected to witness noteworthy growth in the foreseen future. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars. In addition, presently, close to 70% of the market share is captured by players based in North America and Europe. However, in the long run, markets in emerging regions, such as countries based in Asia, MENA and rest of the world are anticipated to grow at a faster pace.

Example Players in the Modular Facilities Market

Examples of players engaged in this domain (which have also been profiled in this report) include (in alphabetical order) Cytiva, G-CON Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule.

The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

  • An executive summary of the key insights captured during our research, offering a high-level view on the current state of the modular facilities market and its likely evolution in the short to mid and long term.
  • A brief introduction to important concepts related to modular facilities, featuring information on different types of modular constructs, as well as primary applications of modular facilities in the pharmaceutical and biotechnology domains. Further, this chapter highlights the recent advancements that have been reported in this market space.
  • A detailed assessment of the current market landscape of modular facilities, highlighting the contributions of various service providers, along with information on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia and rest of the world, type of industry served (pharmaceutical, biotechnology, other industries), geographical coverage (North America, Europe, Asia and rest of the world), GMP compliance, type of modular construction (relocatable, permanent), type of material (steel, wood and concrete) and quality certification(s) obtained.
  • A detailed review of the overall landscape of the modular cleanroom providers market, highlighting the contributions of various players, along with information on their year of establishment, company size (small, mid-sized and large) , location of headquarters (North America, Europe, Asia, MENA and rest of the world), type of industry served (pharmaceutical, biotechnology), type of modular cleanroom offered (hardwall, softwall and unspecified), type of cleanroom component offered (air handling units, HEPA filters, ULPA filters, laminar air flow units, air showers, pass throughs, biosafety cabinets, cleanroom furniture, plumbing / piping, lighting / electrical, doors and windows) and quality certification(s) obtained.
  • An in-depth company competitiveness analysis of modular facility service providers, segmented into three categories, namely small (2-50 employees), mid-sized (51-500 employees) and large (>500 employees) players. Within the respective peer groups, companies were ranked based on various relevant parameters, such as service strength (based on the years of experience), company competitiveness (based on parameters, such as type of industry served, GMP compliance, type of modular construction and type of material), as well as partnership activity (in terms of number of partnerships and type of agreements).
  • Elaborate profiles of prominent players that are currently engaged in offering modular facilities. Each profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective service portfolio, recent developments and an informed future outlook.
  • An analysis of the partnerships inked between various stakeholders in this domain, during the period 2012-2022, featuring a detailed set of analyses based on various parameters, such as year of partnership, type of partnership, type of product, type of modular facility, location of modular facility, geographical location of the companies involved and most active players.
  • A detailed case study on modular projects undertaken by modular facility manufacturers in the pharmaceutical and biotechnology industry, along with information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility.
  • An insightful analysis on facility construction trends observed in the pharmaceutical industry over the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with the information on number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters.
  • An insightful framework that enables a thorough examination of the cost and time related offered by the use of different modular approaches, by considering multiple parameters, including long-term benefits and sustainability, to identify the most appropriate solution for various types of end users and enabling them to make informed decisions.
  • A detailed market forecast analysis to estimate the existing market size and the future opportunity for modular facility manufacturers, till 2035; the overall opportunity has been distributed across various segments, such as size of facility (small, mid-sized, large and very large), type of industry served (pharmaceutical and biotechnology), type of modular construct (hybrid skid modular constructs, skid-mounted modular constructs, plug-and-play modular constructs, truckable modular constructs and other modular constructs), type of construction component (process equipment, base building, mechanical, electrical and plumbing system, process commodities and other construction components), purpose of facility (manufacturing facilities, aseptic filling facilities, research and development facilities and other facilities), scale of operation (clinical and commercial), type of product (cell and gene therapies, vaccines, biosimilars, monoclonal antibodies, advanced pharmaceuticals, sterile products, viral vectors and other products), type of expansion (new facilities, facility expansions and planned expansions), type of modular construction (relocatable modular construction, permanent modular construction), type of material (steel, wood and concrete) and key geographical regions (North America, Europe, Asia, Middle East And North Africa, and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.
  • A review of emerging industry trends, including the combination of single-use technologies / continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
  • A detailed discussion on the various growth drivers, such as development of personalized medicines, biosimilars, orphan drugs and anticipated increase in the adoption of modular solutions in the emerging markets by pharmaceutical / biopharmaceutical CMOs.

The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders:

  • Maik Jornitz (Chief Executive Officer, G-CON Manufacturing)
  • Par Almhem (President, ModWave)
  • Vernon Solomon (President, Environmental Systems Corporation)
  • Francois Abiven (Ex-President Life Sciences and Chemicals, Exyte)
  • Mark Koers (Executive Vice President, Sales and Marketing, Modular Devices)
  • Luca Mussati (Vice President Pharmaceutical and Biotechnology, Exyte)
  • Ward Patton (Director of Sales, Subzero Engineering)
  • Wes Temple (Director of Marketing, Vernick)
  • Sulogna Roy (Ex-Sales Manager, Zeton)
  • Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market over the coming 13 years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Question 1: What is modular manufacturing?

Answer: Modular facilities are prefabricated buildings that are built using multiple sections, often known as modules. To provide more context, modular constructs are designed, engineered and manufactured off-site, and later delivered to relevant project site for final installation. Further, integrated assemblies are joined together to create facilities of significant size, housing multiple functions and equipment.

Question 2: Which material is most widely used for the construction of modular facilities?

Answer: Steel and wood are the most commonly used materials for building pre-engineered builds. Of these, steel is usually employed to construct permanent buildings since they are built for use over longer periods of time. On the other hand, wood is generally more suitable for building relocatable constructs as the material is lightweight and hence, allows easy relocation.

Question 3: Which types of partnerships are being inked by modular facility providers?

Answer: Full facility construction agreements, service alliances and cleanroom construction agreements are the most common partnership models adopted by stakeholders engaged in the modular facilities domain.

Question 4: Which healthcare sector is rapidly employing modular facilities?

Answers: Currently, the pharmaceutical industry is leading the adoption of modular facilities in the healthcare sector. On the other hand, the modular facilities market for biotechnology industry is expected to grow at 11%, capturing a considerable market share in the foreseen future.

Question 5: How is the modular facilities market likely to grow in the future?

Answers: The global modular facilities market is anticipated to grow at a compound annualized growth rate of 10%, till 2035.

Question 6: Which region is leading the modular facilities market?

Answers: North America and Europe, combined, hold 70% share of the global modular facilities market. In the longer run, emerging regions, such as Asia, are likely to grow at faster pace.

CHAPTER OUTLINES

  • Chapter 1: is a preface providing an introduction to the full report, Modular Facilities in the Pharmaceutical / Biotechnology Sector (3rd Edition), 2023-2035.
  • Chapter 2: is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of modular facility services market and its likely evolution in the short to mid and long term.
  • Chapter 3: provides a general overview of concepts related to modular facilities, featuring information on different types of modular constructs, primary applications of modular facilities in the pharmaceutical and biotechnology domain. This chapter features details related to the recent advancements that have been reported in this market space.
  • Chapter 4: includes a detailed analysis of the current market landscape of over 50 modular facility manufacturers, based on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia and rest of the world), type of industry served (pharmaceutical, biotechnology, other industries), geographical coverage (North America, Europe, Asia, rest of the world), GMP compliance, type of modular construction (relocatable, permanent), type of material (steel, wood and concrete) and quality certification(s) obtained.
  • Chapter 5: includes a detailed analysis of the current market landscape of over 250 modular cleanroom providers, based on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia, MENA and rest of the world), type of industry served (pharmaceutical, biotechnology, other industries), type of modular cleanroom offered (hardwall, softwall and unspecified), type of cleanroom component offered (air handling units, HEPA filters, ULPA filters, laminar air flow units, air showers, pass throughs, biosafety cabinets, cleanroom furniture, plumbing / piping, lighting / electrical, doors and windows) and quality certification(s) obtained.
  • Chapter 6: provides an in-depth competitiveness analysis of modular facilities service providers, segmented into three categories, namely small (2-50 employees), mid-sized (51-500 employees) and large (>500 employees). Within the peer group, companies were ranked based on various relevant parameters, such as supplier power (based on the years of experience) and portfolio strength (based on parameters, such as type of industry served, GMP compliance, type of modular construction and type of material), as well as partnership activity (in terms of number of partnerships and type of agreements).
  • Chapter 7: includes detailed profiles of prominent players (shortlisted based on company competitiveness analysis) engaged in providing modular facility services. Each company profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details of their respective service portfolio, recent developments and an informed future outlook.
  • Chapter 8: presents an in-depth analysis and discussion on the various partnerships inked between various stakeholders in this domain, during the period 2012-2022, featuring a detailed set of analyses based on various parameters, such as year of partnership, type of partnership, type of product, type of modular facility, location of modular facility, geographical location of the companies involved and most active players.
  • Chapter 9: provides a detailed analysis of modular projects undertaken across key geographical regions, featuring information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility.
  • Chapter 10: present an insightful analysis on facility construction trends in the pharmaceutical industry for the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with information on their number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters.
  • Chapter 11: presents an insightful framework that enables a thorough examination of the cost and time related offered by the use of different modular approaches, by considering multiple parameters, including long-term benefits and sustainability, to identify the most appropriate solution for various types of end users and enabling them to make informed decisions.
  • Chapter 12: presents an insightful market forecast analysis, highlighting the likely growth of modular facilities services market till 2035. We have segmented the market across size of facility (small, mid-sized, large and very large), type of industry served (pharmaceutical and biotechnology), type of modular construct (hybrid skid modular constructs, skid-mounted modular constructs, plug-and-play modular constructs, truckable modular constructs and other modular constructs), type of construction component (process equipment costs, base building costs, mechanical, electrical and plumbing system costs, process commodities costs and other costs), purpose of facility (manufacturing facilities, aseptic filling facilities, research and development facilities and other facilities), scale of operation (clinical, commercial), type of product (cell and gene therapies, vaccines, biosimilars, monoclonal antibodies, advanced pharmaceuticals, sterile products, viral vectors and other products), type of expansion (new facilities, facility expansions and planned expansions), type of modular construction (relocatable modular construction, permanent modular construction), type of material (steel, wood and concrete) and key geographical regions (North America, Europe, Asia, Middle East and North Africa, and rest of the world).
  • Chapter 13: provides information on emerging trends, including the combination of single-use technologies / continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
  • Chapter 14: provides information on various growth drivers, such as the development of personalized medicines, biosimilars, orphan drugs and the anticipated increase in the adoption of modular solutions in emerging markets by pharmaceutical / biopharmaceutical CMOs. Further, the chapter also highlights current trends, such as expansion of existing facilities and adoption of modular facilities by emerging start-ups and small companies.
  • Chapter 15: is a collection of interview transcripts of discussions held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular), Vernon Solomon (President, Environmental Systems Corporation), Francois Abiven (Executive Vice President Global Business Unit BLS, Exyte) , Luca Mussati (Vice President Technology and Innovation, Exyte), Maik Jornitz (Chief Executive Officer, G-CON Manufacturing), Mark Koers (Executive Vice President, Sales and Marketing, Modular Devices), Par Almhem (President, ModWave), Ward Patton (Director of Sales, Subzero Engineering), Wes Temple (Director of Marketing, Vernick) and Sulogna Roy (Ex-Sales Manager, Zeton).
  • Chapter 16: is an appendix, which provides tabulated data and numbers for all the figures provided in the report.
  • Chapter 17: is an appendix, which contains the list of companies and organizations mentioned in the report.
Product Code: RA100413

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Historical Background
  • 3.3. The Concept of Modular Facilities
    • 3.3.1. Types of Modular Constructs
    • 3.3.2. Modular Construction Process
  • 3.4. Modular Construction in the Pharmaceutical Industry
    • 3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
    • 3.4.2. Modular Pharmaceutical Cleanrooms
      • 3.4.2.1. Cleanroom Classifications and Current Standards
      • 3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
  • 3.5. Advantages of Modular Cleanrooms
  • 3.6. Challenges and Future Prospects

4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS

  • 4.1. Chapter Overview
  • 4.2. Modular Facility Manufacturers: Overall Market Landscape
    • 4.2.1 Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Year of Establishment and Location of Headquarters
    • 4.2.5. Analysis by Company Size and Location of Headquarters
    • 4.2.6. Analysis by Type of Industry Served
    • 4.2.7. Analysis by Geographical Coverage
    • 4.2.8. Analysis by Type of Industry Served and Geographical Coverage
    • 4.2.9. Analysis by GMP Compliance
    • 4.2.10. Analysis by Geographical Coverage and GMP Compliance
    • 4.2.11. Analysis by Type of Modular Construction
    • 4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
    • 4.2.13. Analysis by Type of Material
    • 4.2.14. Analysis by Type of Modular Construction and Type of Material
    • 4.2.15. Analysis of Historical and Current Market Landscape Trends
      • 4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served

5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS

  • 5.1. Chapter Overview
  • 5.2. Modular Cleanroom Providers: Overall Landscape
    • 5.2.1. Analysis by Year of Establishment
    • 5.2.2. Analysis by Company Size
    • 5.2.3. Analysis by Location of Headquarters
    • 5.2.4. Analysis by Year of Establishment and Location of Headquarters
    • 5.2.5. Analysis by Company Size and Location of Headquarters
    • 5.2.6. Analysis by Type of Industry Served
    • 5.2.7. Analysis by Location of Headquarters and Type of Industry Served
    • 5.2.8. Analysis by Type of Modular Cleanroom Offered
    • 5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
    • 5.2.10. Analysis by Type of Cleanroom Component Offered
    • 5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
    • 5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
    • 5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
    • 5.2.14. Analysis by Quality Certifications Obtained

6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS

  • 6.1 Chapter Overview
  • 6.2 Assumptions / Key Parameters
  • 6.3 Methodology
  • 6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
    • 6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
    • 6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
    • 6.4.3. Company Competitiveness Analysis: Small Companies
    • 6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
    • 6.4.5. Company Competitiveness Analysis: Large Companies

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Cytiva
    • 7.2.1. Company Overview
    • 7.2.2. Modular Facility-related Services
    • 7.2.3. Modular Projects
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. G-CON Manufacturing
    • 7.3.1. Company Overview
    • 7.3.2. Modular Facility-related Services
    • 7.3.3. Modular Projects
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Germfree
    • 7.4.1. Company Overview
    • 7.4.2. Modular Facility-related Services
    • 7.4.3. Modular Projects
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. IPM Technologies
    • 7.5.1. Company Overview
    • 7.5.2. Modular Facility-related Services
    • 7.5.3. Modular Projects
    • 7.5.4. Recent Developments and Future Outlook
  • 7.6. KeyPlants
    • 7.6.1. Company Overview
    • 7.6.2. Modular Facility-related Services
    • 7.6.3. Modular Projects
    • 7.6.4. Recent Developments and Future Outlook
  • 7.7. ModuleCo Pharma
    • 7.7.1. Company Overview
    • 7.7.2. Modular Facility-related Services
    • 7.7.3. Modular Projects
    • 7.7.4. Recent Developments and Future Outlook
  • 7.8. NNE
    • 7.8.1. Company Overview
    • 7.8.2. Modular Facility-related Services
    • 7.8.3. Modular Projects
    • 7.8.4. Recent Developments and Future Outlook
  • 7.9. Pharmadule
    • 7.9.1. Company Overview
    • 7.9.2. Modular Facility-related Services
    • 7.9.3. Modular Projects
    • 7.9.4. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Modular Facility Manufacturers: Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year of Partnership and Type of Partnership
    • 8.3.4. Analysis by Type of Product
    • 8.3.5. Analysis by Type of Partnership and Type of Product
    • 8.3.6. Analysis by Type of Modular Facility
    • 8.3.7. Analysis by Type of Product and Type of Modular Facility
    • 8.3.8. Most Active Players: Analysis by Number of Partnerships
    • 8.3.9. Analysis by Location of Partner's Headquarters
    • 8.3.10. Analysis by Location of Modular Facility
    • 8.3.11. Analysis by Type of Partnership and Location of Modular Facility
    • 8.3.12. Analysis by Type of Product and Location of Modular Facility
    • 8.3.13. Intercontinental and Intracontinental Partnerships
    • 8.3.14. Analysis by Country

9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

  • 9.1. Chapter Overview
  • 9.2. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
    • 9.3.1. Analysis by Type of Modular Facility
    • 9.3.2. Analysis by Size of Modular Facility
    • 9.3.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
    • 9.3.4. Most Active Clients: Analysis by Number of Projects Received
    • 9.3.5. Analysis by Location of Modular Facility
    • 9.3.6. Analysis by Type of Facility and Size of Modular Facility
    • 9.3.7. Analysis by Client and Location of Facility

10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY

  • 10.1. Chapter Overview
  • 10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
    • 10.2.1. Analysis by Number of Facilities Delivered
    • 10.2.2. Analysis by Type of Facility
    • 10.2.3. Analysis by Purpose of Facility
    • 10.2.4. Analysis by Type of Facility and Purpose of Facility
    • 10.2.5. Analysis by Type of Investment
    • 10.2.6. Analysis by Purpose of Facility and Type of Investment
    • 10.2.7. Analysis by Size of Facility
    • 10.2.8. Analysis by Type of Facility and Size of Facility
    • 10.2.9. Analysis by Purpose of Facility and Size of Facility
    • 10.2.10. Analysis by Location of Headquarters
    • 10.2.11. Analysis by Location of Facility
    • 10.2.12. Analysis by Type of Facility and Location of Facility

11. COST-TIME OPTIMIZATION FRAMEWORK

  • 11.1. Chapter Overview
  • 11.2. Key Assumptions and Methodology
  • 11.3. Factors Influencing Modular Construction
    • 11.3.1. Intrinsic Factors
    • 11.3.2. Extrinsic Factors
  • 11.4. Cost Efficiency Analysis
  • 11.5. Time-Benefit Analysis
  • 11.6. Concluding Remarks

12. MARKET FORECAST

  • 12.1. Chapter Overview
  • 12.2. Forecast Methodology and Key Assumptions
  • 12.3. Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector,

2023-2035

  • 12.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Size of Facility, 2023 and 2035
    • 12.4.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-203
    • 12.4.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035
    • 12.4.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035
    • 12.4.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035
  • 12.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Industry Served, 2023 and 2035
    • 12.5.1. Modular Facilities Market in the Pharmaceutical Industry, 2023-2035
    • 12.5.2. Modular Facilities Market in the Biotechnology Industry, 2023-2035
  • 12.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construct, 2023 and 2035
    • 12.6.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035
    • 12.6.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035
    • 12.6.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035
    • 12.6.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035
    • 12.6.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035
  • 12.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Construction Component, 2023 and 2035
    • 12.7.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035
    • 12.7.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Buildings, 2023-2035
    • 12.7.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing Systems, 2023-2035
    • 12.7.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035
    • 12.7.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035
  • 12.8 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Purpose of Facility, 2023 and 2035
    • 12.8.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing, 2023-2035
    • 12.8.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling, 2023-2035
    • 12.8.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development, 2023-2035
    • 12.8.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Purposes, 2023-2035
  • 12.9. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Scale of Operation, 2023 and 2035
    • 12.9.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Scale, 2023-2035
    • 12.9.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Scale, 2023-2035
  • 12.10. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Product, 2023 and 2035
    • 12.10.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035
    • 12.10.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035
    • 12.10.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035
    • 12.10.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035
    • 12.10.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035
    • 12.10.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035
    • 12.10.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035
    • 12.10.8. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035
  • 12.11. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Expansion, 2023 and 2035
    • 12.11.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035
    • 12.11.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035
    • 12.11.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035
  • 12.12. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construction, 2023 and 2035
    • 12.12.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035
    • 12.12.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035
  • 12.13. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Material 2023 and 2035
    • 12.13.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035
    • 12.13.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035
    • 12.13.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035
  • 12.14. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Geography, 2023 and 2035
    • 12.14.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035
    • 12.14.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035
    • 12.14.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035
    • 12.14.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035
    • 12.14.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035
  • 12.15. Concluding Remarks

13. PREVALENT AND EMERGING INDUSTRY TRENDS

  • 13.1. Chapter Overview
  • 13.2. Adoption of Modular Facilities
  • 13.3. Expansion of Existing Service Portfolio
  • 13.4. Integration of Advanced Technologies
    • 13.4.1. Single-use Technologies
    • 13.4.2. Continuous Processing Technologies
    • 13.4.3. Other Advanced Technologies

14. FUTURE GROWTH OPPORTUNITIES

  • 14.1. Chapter Overview
  • 14.2. Visibility Amongst Start-Ups
  • 14.3. Popularity Amongst Contract Manufacturing Organizations
  • 14.4. Expansion of Existing Facilities
  • 14.5. Adoption for Production of Biosimilars
  • 14.6. Additional Opportunities
  • 14.7. Key Growth Drivers for Modular Construction
  • 14.8. Market Attractiveness in Emerging regions

15. CONCLUSION

16. EXECUTIVE INSIGHTS

  • 16.1. Chapter Overview
  • 16.2. Avon Modular
    • 16.2.1. Company Snapshot
    • 16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)
  • 16.3. Environmental Systems Corporation
    • 16.3.1. Company Snapshot
    • 16.3.2. Interview Transcript: Vernon Solomon (President)
  • 16.4. Exyte
    • 16.4.1. Company Snapshot
    • 16.4.2. Interview Transcript: Francois Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)
  • 16.5. G-CON Manufacturing
    • 16.5.1. Company Snapshot
    • 16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)
  • 16.6. Modular Devices
    • 16.6.1. Company Snapshot
    • 16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)
  • 16.7. ModWave
    • 16.7.1. Company Snapshot
    • 16.7.2. Interview Transcript: Par Almhem (President)
  • 16.8. Subzero Engineering
    • 16.8.1. Company Snapshot
    • 16.8.2. Interview Transcript: Ward Patton (Director of Sales)
  • 16.9. Vernick
    • 16.9.1. Company Snapshot
    • 16.9.2. Interview Transcript: Wes Temple (Director of Marketing)
  • 16.10. Zeton
    • 16.10.1. Company Snapshot
    • 16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

Product Code: RA100413

LIST OF TABLES

  • Table 3.1 Cleanroom Classification Standards
  • Table 3.2 ISO and FED STD 209E: Cleanroom Classification
  • Table 4.1 Modular Facility Manufacturers: List of Service Providers
  • Table 4.2 Modular Facility Manufacturers: Information on Type of Industry Served, GMP Compliant Construction and Geographical Coverage
  • Table 4.3 Modular Facility Manufacturers: Information on Type of Modular Construction and Type of Material
  • Table 4.4 Modular Facility Manufacturers: List of Quality Certifications Obtained
  • Table 5.1 Modular Cleanroom Providers: List of Companies
  • Table 5.2 Modular Cleanroom Providers: Type of Industry Served
  • Table 5.3 Modular Cleanroom Providers: Type of Modular Cleanroom Offered
  • Table 5.4 Modular Cleanroom Providers: Type of Cleanroom Component Offered
  • Table 5.5 Modular Cleanroom Providers: List of Regulatory Approvals and Certifications Obtained
  • Table 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
  • Table 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
  • Table 6.3 Company Competitiveness Analysis: List of Small players
  • Table 6.4 Company Competitiveness Analysis: List of Mid-sized players
  • Table 6.5 Company Competitiveness Analysis: List of Large players
  • Table 7.1 List of Companies Profiled
  • Table 7.2 Cytiva: Key Highlights
  • Table 7.3 Cytiva: Modular Facility-Related Services
  • Table 7.4 Cytiva: Single-Use Technology Portfolio
  • Table 7.5 Cytiva: Modular Projects
  • Table 7.6 Cytiva: Recent Developments and Future Outlook
  • Table 7.7 G-CON Manufacturing: Key Highlights
  • Table 7.8 G-CON Manufacturing: Modular Facility-Related Services
  • Table 7.9 G-CON Manufacturing: Modular Projects
  • Table 7.10 G-CON Manufacturing: Recent Developments and Future Outlook
  • Table 7.11 Germfree Laboratories: Key Highlights
  • Table 7.12 Germfree Laboratories: Modular Facility-Related Services
  • Table 7.13 Germfree Laboratories: Key Features of Modules
  • Table 7.14 Germfree Laboratories: Recent Developments and Future Outlook
  • Table 7.15 IPM Technologies: Key Highlights
  • Table 7.16 IPM Technologies: Types of Modular Production Units
  • Table 7.17 KeyPlants: Key Highlights
  • Table 7.18 KeyPlants: Recent Developments and Future Outlook
  • Table 7.19 ModuleCo Pharma: Key Highlights
  • Table 7.20 ModuleCo Pharma: Key Features of Modular Facilities
  • Table 7.21 NNE: Key Highlights
  • Table 7.22 NNE: Modular Projects
  • Table 7.23 NNE: Recent Developments and Future Outlook
  • Table 7.24 Pharmadule: Key Highlights
  • Table 7.25 Pharmadule: Modular Projects
  • Table 7.26 Pharmadule: Recent Developments and Future Outlook
  • Table 8.1 Modular Facility Manufacturers: List of Partnerships and Collaborations, 2012-2022
  • Table 8.2 Modular Facility Manufacturers: List of Partnerships and Collaborations, Information on Type of Agreement 2012-2022
  • Table 9.1 Modular Facilities: List of Modular Projects
  • Table 9.2 Modular Facilities and Conventional Facilities: Comparison of Construction Investment and Financial Returns
  • Table 10.1 Conventional Facilities: Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry (Top 20 Companies): Historical Data, January 2016-2022
  • Table 10.2 Conventional Facilities: Information on Location of Headquarters, Area of Facility and Size of Facility
  • Table 16.1 Avon Modular: Company Snapshot
  • Table 16.2. Environmental Systems Corporation: Company Snapshot
  • Table 16.3 Exyte: Company Snapshot
  • Table 16.4 G-CON Manufacturing: Company Snapshot
  • Table 16.5 Modular Devices: Company Snapshot
  • Table 16.6 ModWave: Company Snapshot
  • Table 16.7 Subzero Simplex Cleanrooms: Company Snapshot
  • Table 16.8 Vernick Cleanroom Design and Construction: Company Snapshot
  • Table 16.9 Zeton: Company Snapshot
  • Table 17.1 Modular Facility Manufacturers: Distribution by Year of Establishment
  • Table 17.2 Modular Facility Manufacturers: Distribution by Company Size
  • Table 17.3 Modular Facility Manufacturers: Distribution by Location of Headquarters (Region-wise)
  • Table 17.4 Modular Facility Manufacturers: Distribution by Location of Headquarters (Country-wise)
  • Table 17.5 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
  • Table 17.6 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
  • Table 17.7 Modular Facility Manufacturers: Distribution by Type of Industry Served
  • Table 17.8 Modular Facility Manufacturers: Distribution by Geographical Coverage
  • Table 17.9 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
  • Table 17.10 Modular Facility Manufacturers: Distribution by GMP Compliance
  • Table 17.11 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
  • Table 17.12 Modular Facility Manufacturers: Distribution by Type of Modular Construction
  • Table 17.13 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
  • Table 17.14 Modular Facility Manufacturers: Distribution by Type of Material
  • Table 17.15 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material
  • Table 17.16 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
  • Table 17.17 Modular Facility Manufacturers: Distribution by Quality Certifications Obtained
  • Table 17.18 Modular Cleanroom Providers: Distribution by Year of Establishment
  • Table 17.19 Modular Cleanroom Providers: Distribution by Company Size
  • Table 17.20 Modular Cleanroom Providers: Distribution by Location of Headquarters (Region-wise)
  • Table 17.21 Modular Cleanroom Providers: Distribution by Location of Headquarters (Country-wise)
  • Table 17.22 Modular Cleanroom Providers: Distribution by Year of Establishment and Location of Headquarters
  • Table 17.23 Modular Cleanroom Providers: Distribution by Company Size and Location of Headquarters
  • Table 17.24 Modular Cleanroom Providers: Distribution by Type of Industry Served
  • Table 17.25 Modular Cleanroom Providers: Distribution by Type of Industry Served and Location of Headquarters
  • Table 17.26 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom Offered
  • Table 17.27 Modular Cleanroom Providers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
  • Table 17.28 Modular Cleanroom Providers: Distribution by Type of Cleanroom Component Offered
  • Table 17.29 Modular Cleanroom Providers: Distribution by Type of Industry Served and Cleanroom Component Offered
  • Table 17.30 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
  • Table 17.31 Modular Cleanroom Providers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
  • Table 17.32 Modular Cleanroom Providers: Distribution by Quality Certifications Obtained
  • Table 17.33 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
  • Table 17.34 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 17.35 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
  • Table 17.36 Partnerships and Collaborations: Distribution by Type of Product
  • Table 17.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
  • Table 17.38 Partnerships and Collaborations: Distribution by Type of Modular Facility
  • Table 17.39 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
  • Table 17.40 Most Active Players: Distribution by Number of Partnerships
  • Table 17.41 Partnerships and Collaborations: Distribution by Location of Partner's Headquarters
  • Table 17.42 Partnerships and Collaborations: Distribution by Location of Modular Facility
  • Table 17.43 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
  • Table 17.44 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
  • Table 17.45 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Table 17.46 Partnerships and Collaborations: Location of Headquarters (Country-wise) Distribution
  • Table 17.47 Modular Facilities: Distribution by Type of Modular Facility
  • Table 17.48 Modular Facilities: Distribution by Size of Facility
  • Table 17.49 Most Active Manufacturers: Distribution by Number of Projects Delivered
  • Table 17.50 Most Active Clients: Distribution by Number of Projects Received
  • Table 17.51 Modular Facilities: Distribution by Location of Modular Facility
  • Table 17.52 Modular Facilities: Distribution by Type of Facility and Size of Modular Facility
  • Table 17.53 Modular Facilities: Distribution by Client and Location of Facility
  • Table 17.54 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
  • Table 17.55 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
  • Table 17.56 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
  • Table 17.57 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
  • Table 17.58 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
  • Table 17.59 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
  • Table 17.60 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
  • Table 17.61 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
  • Table 17.62 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Size of Facility
  • Table 17.63 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
  • Table 17.64 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
  • Table 17.65 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
  • Table 17.66 Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector,

Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

  • Table 17.67 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Size of Facility, 2023 and 2035
  • Table 17.68 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.69 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.70 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.71 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.72 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Industry Served, 2023 and 2035
  • Table 17.73 Modular Facilities Market in the Pharmaceutical Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.74 Modular Facilities Market in the Biotechnology Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.75 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construct, 2023 and 2035
  • Table 17.76 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.77 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.78 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.79 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.80 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.81 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Construction Component, 2023 and 2035
  • Table 17.82 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.83 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Building, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.84 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing System, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.85 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.86 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.87 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Purpose of Facility, 2023 and 2035
  • Table 17.88 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.89 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.90 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.91 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Facilities, 2023-2035, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.92 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Scale of Operation, 2023 and 2035
  • Table 17.93 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.94 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.95 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Product, 2023 and 2035
  • Table 17.96 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.97 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.98 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.99 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.100 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.101 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.102 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.103 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.104 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Expansion, 2023 and 2035
  • Table 17.105 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.106 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.107 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.108 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construction, 2023 and 2035
  • Table 17.109 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.110 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.111 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Material 2023 and 2035
  • Table 17.112 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.113 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.114 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.115 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Geography, 2023 and 2035
  • Table 17.116 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.117 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.118 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.119 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 17.120 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)

LIST OF FIGURES

  • Figure 2.1 Executive Summary: Modular Facility Manufacturers
  • Figure 2.2 Executive Summary: Modular Cleanroom Providers
  • Figure 2.3 Executive Summary: Partnerships and Collaborations
  • Figure 2.4 Executive Summary: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
  • Figure 2.5 Executive Summary: Facility Construction Trends in the Pharmaceutical Industry
  • Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Modular Construction: Applications
  • Figure 3.2 Modular Construction: Processes Involved
  • Figure 3.3 Modular and Conventional Buildings: Construction Timeline
  • Figure 3.4 Modular Construction: Advantages
  • Figure 4.1 Modular Facility Manufacturers: Distribution by Year of Establishment
  • Figure 4.2 Modular Facility Manufacturers: Distribution by Company Size
  • Figure 4.3 Modular Facility Manufacturers: Distribution by Location of Headquarters
  • Figure 4.4 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
  • Figure 4.5 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
  • Figure 4.6 Modular Facility Manufacturers: Distribution by Type of Industry Served
  • Figure 4.7 Modular Facility Manufacturers: Distribution by Geographical Coverage
  • Figure 4.8 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
  • Figure 4.9 Modular Facility Manufacturers: Distribution by GMP Compliance
  • Figure 4.10 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
  • Figure 4.11 Modular Facility Manufacturers: Distribution by Type of Modular Construction
  • Figure 4.12 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
  • Figure 4.13 Modular Facility Manufacturers: Distribution by Type of Material
  • Figure 4.14 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material
  • Figure 4.15 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
  • Figure 5.1 Modular Cleanroom Providers: Distribution by Year of Establishment
  • Figure 5.2 Modular Cleanroom Providers: Distribution by Company Size
  • Figure 5.3 Modular Cleanroom Providers: Distribution by Location of Headquarters
  • Figure 5.4 Modular Cleanroom Providers: Distribution by Year of Establishment and Location of Headquarters
  • Figure 5.5 Modular Cleanroom Providers: Distribution by Company Size and Location of Headquarters
  • Figure 5.6 Modular Cleanroom Providers: Distribution by Type of Industry Served
  • Figure 5.7 Modular Cleanroom Providers: Distribution by Type of Industry Served and Location of Headquarters
  • Figure 5.8 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom Offered
  • Figure 5.9 Modular Cleanroom Providers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
  • Figure 5.10 Modular Cleanroom Providers: Distribution by Type of Cleanroom Component Offered
  • Figure 5.11 Modular Cleanroom Providers: Distribution by Type of Industry Served and Cleanroom Component Offered
  • Figure 5.12 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
  • Figure 5.13 Modular Cleanroom Providers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
  • Figure 5.14 Modular Cleanroom Providers: Distribution by Quality Certifications Obtained
  • Figure 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
  • Figure 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
  • Figure 6.3 Company Competitiveness Analysis: Small Companies
  • Figure 6.4 Company Competitiveness Analysis: Mid-sized Companies
  • Figure 6.5 Company Competitiveness Analysis: Large Companies
  • Figure 7.1 Cytiva: Stages of KUBio Facility Project
  • Figure 7.2 Germfree: Types of Lab Modules
  • Figure 7.3 IPM Technologies: Features of ISOdule Units
  • Figure 7.4 IPM Technologies: Applications of Modular Facilities
  • Figure 7.5 KeyPlants: Modular Facility-related Services
  • Figure 7.6 NNE: Modular Facility-related Services
  • Figure 7.7 NNE: Benefits of Bio on Demand Facility
  • Figure 7.8 Pharmadule: Modular Facility Services
  • Figure 7.9 Pharmadule: Process of Modular Facility Construction
  • Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
  • Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
  • Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
  • Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
  • Figure 8.6 Partnerships and Collaborations: Distribution by Type of Modular Facility
  • Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
  • Figure 8.8 Most Active Players: Distribution by Number of Partnerships
  • Figure 8.9 Partnerships and Collaborations: Distribution by Location of Partner's Headquarters
  • Figure 8.10 Partnerships and Collaborations: Distribution by Location of Modular Facility
  • Figure 8.11 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
  • Figure 8.12 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
  • Figure 8.13 Intercontinental and Intracontinental Partnerships
  • Figure 8.14 Partnerships and Collaborations: Country-wise Distribution
  • Figure 9.1 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Modular Facility
  • Figure 9.2 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Size of Modular Facility
  • Figure 9.3 Most Active Manufacturers: Distribution by Number of Projects Delivered
  • Figure 9.4 Most Active Clients: Distribution by Number of Projects Received
  • Figure 9.5 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Location of Modular Facility
  • Figure 9.6 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Facility and Size of Modular Facility
  • Figure 9.7 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Client and Location of Facility
  • Figure 9.8 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Modular versus Conventional Construction Methods
  • Figure 9.9 Modular and Conventional Facilities: Comparison of Construction Timelines
  • Figure 9.10 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Process
  • Figure 9.11 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Timeline
  • Figure 10.1 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
  • Figure 10.2 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
  • Figure 10.3 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
  • Figure 10.4 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
  • Figure 10.5 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
  • Figure 10.6 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
  • Figure 10.7 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
  • Figure 10.8 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
  • Figure 10.9 Facility Construction Trends in the Pharmaceutical Industry: Purpose of Facility and Size of Facility
  • Figure 10.10 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
  • Figure 10.11 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
  • Figure 10.12 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
  • Figure 11.1 Cost Efficiency Analysis: Comparison of Intrinsic Factors
  • Figure 11.2 Cost Efficiency Analysis: Comparison of Extrinsic Factors
  • Figure 11.3 Time-Benefit Analysis: Comparison of Intrinsic Factors
  • Figure 11.4 Time-Benefit Analysis: Comparison of Extrinsic Factors
  • Figure 11.5 Cost-Time Optimization Analysis: Overall Evaluation
  • Figure 12.1 Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector,

2023-2035 (USD Million)

  • Figure 12.2 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Size of Facility, 2023 and 2035
  • Figure 12.3 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-2035 (USD Million)
  • Figure 12.4 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035 (USD Million)
  • Figure 12.5 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035 (USD Million)
  • Figure 12.6 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035 (USD Million)
  • Figure 12.7 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Industry Served, 2023 and 2035
  • Figure 12.8 Modular Facilities Market in the Pharmaceutical Industry, 2023-2035 (USD Million)
  • Figure 12.9 Modular Facilities Market in the Biotechnology Industry, 2023-2035 (USD Million)
  • Figure 12.10 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construct, 2023 and 2035
  • Figure 12.11 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035 (USD Million)
  • Figure 12.12 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035 (USD Million)
  • Figure 12.13 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035 (USD Million)
  • Figure 12.14 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035 (USD Million)
  • Figure 12.15 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035 (USD Million)
  • Figure 12.16 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Construction Component, 2023 and 2035
  • Figure 12.17 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035 (USD Million)
  • Figure 12.18 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Building, 2023-2035 (USD Million)
  • Figure 12.19 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing System, 2023-2035 (USD Million)
  • Figure 12.20 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035 (USD Million)
  • Figure 12.21 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035 (USD Million)
  • Figure 12.22 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Purpose of Facility, 2023 and 2035
  • Figure 12.23 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing Facilities, 2023-2035 (USD Million)
  • Figure 12.24 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling Facilities, 2023-2035 (USD Million)
  • Figure 12.25 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development Facilities, 2023-2035 (USD Million)
  • Figure 12.26. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Facilities, 2023-2035 (USD Million)
  • Figure 12.27 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Scale of Operation, 2023 and 2035
  • Figure 12.28 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Operations, 2023-2035 (USD Million)
  • Figure 12.29 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Operations, 2023-2035 (USD Million)
  • Figure 12.30 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Product, 2023 and 2035
  • Figure 12.31 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035 (USD Million)
  • Figure 12.32 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035 (USD Million)
  • Figure 12.33 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035 (USD Million)
  • Figure 12.34 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035 (USD Million)
  • Figure 12.35 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035 (USD Million)
  • Figure 12.36 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035 (USD Million)
  • Figure 12.37 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035 (USD Million)
  • Figure 12.38 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035 (USD Million)
  • Figure 12.39 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Expansion, 2023 and 2035
  • Figure 12.40 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035 (USD Million)
  • Figure 12.41 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035 (USD Million)
  • Figure 12.42 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035 (USD Million)
  • Figure 12.43 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construction, 2023 and 2035
  • Figure 12.44 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035 (USD Million)
  • Figure 12.45 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035 (USD Million)
  • Figure 12.46 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Material 2023 and 2035
  • Figure 12.47 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035 (USD Million)
  • Figure 12.48 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035 (USD Million)
  • Figure 12.49 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035 (USD Million)
  • Figure 12.50 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Geography, 2023 and 2035
  • Figure 12.51 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035 (USD Million)
  • Figure 12.52 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035 (USD Million)
  • Figure 12.53 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035 (USD Million)
  • Figure 12.54 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035 (USD Million)
  • Figure 12.55 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035 (USD Million)
  • Figure 13.1 Modular Facilities: Technological Advancements
  • Figure 14.1 Modular Facilities Market: Future Growth Opportunities
  • Figure 15.1 Concluding Remarks: Modular Facility Manufacturers Market Landscape
  • Figure 15.2 Concluding Remarks: Modular Cleanroom Providers Market Landscape
  • Figure 15.3 Concluding Remarks: Company Competitiveness Analysis
  • Figure 15.4 Concluding Remarks: Partnerships and Collaborations
  • Figure 15.5 Concluding Remarks: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
  • Figure 15.6 Concluding Remarks: Facility Construction Trends in Pharmaceutical Industry
  • Figure 15.7 Concluding Remarks: Roots Analysis Framework
  • Figure 15.8 Concluding Remarks: Market Forecast
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!